Joseph P. Lucia & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Joseph P. Lucia & Associates’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-245	Closed	-$18K	–	448
2022 Q2	$18K	Sell	245 -205	-46%	-$15.4K	0.01%	260
2022 Q1	$40K	Buy	+450	New	+$41.6K	0.02%	208
2021 Q4	–	Sell	-754	Closed	-$95K	–	561
2021 Q3	$95K	Sell	754 -180	-19%	-$23.2K	0.06%	173
2021 Q2	$126K	Sell	934 -215	-19%	-$28.3K	0.08%	151
2021 Q1	$156K	Buy	1,149 +1,059	+1,177%	+$159K	0.07%	128
2020 Q4	$13K	Buy	+90	New	+$11.5K	0.01%	313
2020 Q3	–	Sell	-140	Closed	-$16K	–	460
2020 Q2	$16K	Buy	140 +50	+56%	+$4.92K	0.01%	265
2020 Q1	$7K	Sell	90 -250	-74%	-$22.1K	0.01%	319
2019 Q4	$32K	Sell	340 -50	-13%	-$4.33K	0.03%	210
2019 Q3	$30K	Hold	390	–	–	0.03%	213
2019 Q2	$34K	Hold	390	–	–	0.04%	209
2019 Q1	$36.3K	Buy	+390	New	+$33.2K	0.06%	132

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Joseph P. Lucia & Associates's XBI Position: Q3 2022 in Review

Joseph P. Lucia & Associates sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 245 shares — an estimated $18K sold.

Joseph P. Lucia & Associates first reported a position in XBI in Q1 2019 and held it in 12 quarters. The position peaked at $156K in Q1 2021. 703 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Joseph P. Lucia & Associates reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Joseph P. Lucia & Associates sold 245 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $18K.
Joseph P. Lucia & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 12 quarters.
Joseph P. Lucia & Associates's State Street SPDR S&P Biotech ETF position peaked at $156K in Q1 2021.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q3 2022, filed 28 Oct 2022.